Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

71.25
+0.33500.47%
Volume:333.34K
Turnover:23.58M
Market Cap:9.90B
PE:-9.92
High:71.73
Open:70.15
Low:69.85
Close:70.91
52wk High:88.31
52wk Low:44.91
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.47
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-57.09
PE(LYR):-10.89

Loading ...

Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 16, 2022

Major Issues Report

8-K - Current report
Feb 16, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Major Issues Report

8-K - Current report
Jan 24, 2022

Major Issues Report

8-K - Current report
Jan 07, 2022

Major Issues Report

8-K - Current report
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 09, 2021

Major Issues Report

8-K - Current report
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]